Eva Ulla Lorentzen

7PUBLICATIONS
10CO-AUTHORS
Immunogenetics (incl. genetic immunology)Infectious diseasesNanotoxicology, health and safetyInnate immunityCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2025
SARS-CoV-2 Variant-Specific Antibodies in Vaccinated Inflammatory Bowel Disease Patients.

Eva Ulla Lorentzen, Richard Vollenberg, Rieke Neddermeyer

|Sep 27, 2024
SARS-CoV-2 Infection Enhances Humoral Immune Response in Vaccinated Liver Transplant Recipients.

Jan Basri Adiprasito, Tobias Nowacki, Richard Vollenberg

|Dec 23, 2023
Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort.

Michael Schoefbaenker, Rieke Neddermeyer, Theresa Guenther

|Sep 28, 2023
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects.

Richard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn

|Jul 27, 2022
Broadly Applicable, Virus-Free Dual Reporter Assay to Identify Compounds Interfering with Membrane Fusion: Performance for HSV-1 and SARS-CoV-2.

Nica Classen, Diana Ulrich, Arne Hofemeier

|May 28, 2022
Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study.

Richard Vollenberg, Phil-Robin Tepasse, Eva Lorentzen

Pageof 2

Frequent Collaborators

5 joint publications

Phil-Robin Tepasse

3 joint publications

Tobias Nowacki

2 joint publications

Richard Vollenberg

2 joint publications

Nica Classen